October 27, 2025 | Denver, CO — MedLegalNews.com — In a landmark ruling that could reshape Colorado’s medical malpractice landscape, the Colorado Supreme Court has upheld a $40 million jury award to the family of a patient who died following surgical complications—affirming that state-imposed damages caps do not automatically invalidate jury verdicts when constitutional rights […]
October 24, 2025 | Newark, NJ — MedLegalNews.com — A New Jersey appellate court has upheld a lower court ruling that places full financial liability on a surgeon for a $1.6 million medical malpractice verdict, rejecting arguments that co-defendants should share the damages. The decision reinforces the state’s strict interpretation of comparative negligence in surgical
Surgeon Liable for Full $1.6M Medical Malpractice Verdict (2025) Read Post »
October 22, 2025 | Sacramento, CA — MedLegalNews.com — California has enacted a pair of legislative measures—SB 53 on AI Safety and AB 1415 on healthcare investor transparency—marking a significant shift in how the state governs technology and financial influence in the medical sector. Together, the laws reflect California’s growing emphasis on AI Safety, accountability,
California AI Safety and Healthcare Investor Laws Tighten Oversight (2025) Read Post »
October 20, 2025 | Washington, D.C. — MedLegalNews.com — The U.S. Supreme Court has declined to review a challenge to the Food and Drug Administration’s (FDA) authority over stem cell therapies, effectively upholding lower court rulings that classify certain regenerative treatments as drugs subject to federal oversight. The decision preserves the FDA’s power to regulate
High Court Declines FDA Stem Cell Regulation Fight Read Post »
October 17, 2025 | Beijing, China — MedLegalNews.com — A leading Chinese research organization has accused Gilead Sciences Inc. of infringing on a COVID-19 treatment patent, igniting a high-stakes international dispute over intellectual property and pharmaceutical innovation. The allegations center on compounds related to antiviral formulations used during the global pandemic response. Chinese Institute Claims
Gilead COVID Patent Infringement Dispute with Chinese Research Org (2025) Read Post »
October 15, 2025 | Los Angeles, CA — MedLegalNews.com — In a landmark decision, a California jury has ordered Johnson & Johnson (J&J) to pay $966 million in damages to multiple plaintiffs who claimed that prolonged exposure to the company’s talc-based baby powder caused lung cancer. The verdict, one of the largest against J&J in
J&J Talc Lung Cancer Verdict: $966M California Jury Award Read Post »
October 13, 2025 | Miami, FL — MedLegalNews.com — A Florida federal jury has been told that a 2016 opioid law, which eased restrictions on opioid distribution monitoring, may have undermined the U.S. Drug Enforcement Administration’s (DEA) ability to curb prescription drug abuse. The revelation came amid a high-profile civil case scrutinizing how pharmaceutical distributors
Florida Opioid Law Weakened DEA Oversight, Jury Told (2025) Read Post »
October 10, 2025 | Washington, D.C. — MedLegalNews.com — In the wake of the landmark U.S. v. Skrmetti decision, federal appeals courts in Arkansas and Oklahoma have reaffirmed state bans on gender-affirming medical care for transgender minors, marking a pivotal shift in post-Skrmetti legal precedent. The rulings signal that appellate courts are increasingly willing to
Courts Upholding Gender-Affirming Care Bans After Skrmetti Read Post »
Oct 8, 2025 | Sacramento, CA — MedLegalNews.com — California is preparing to pull back the curtain on who really owns its hospitals and medical networks. Assembly Bill 1415, known as California AB 1415, would require financial investors—including private-equity firms, hedge funds, and management service companies—to notify state regulators before completing any acquisition or control
California Bill AB 1415: Oversight of Private-Equity Ownership in Healthcare Read Post »
October 6, 2025 | Philadelphia, PA — MedLegalNews.com — A federal court in the Eastern District of Pennsylvania has held that Pennsylvania insurer coverage does not extend to a laboratory being sued by a COVID-19 test manufacturer. The ruling marks a significant development in how courts interpret coverage exclusions tied to medical testing and professional
Insurer Escapes Duty to Cover Lab in COVID-19 Tests Suit Read Post »
